Isaac Ceballos Lenza (Isaac Ceballos)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Positive Breast Cancer

Combination Therapy

Clinical Evaluation

Smoking Cessation

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Luis de la Cruz Merino, María Gion, Josefina Cruz Jurado, Vanesa Quiroga, Raquel Andrés, Fernando Moreno, Jose L Alonso-Romero, Manuel Ramos, Esther Holgado, Javier Cortes, Elena López-Miranda, Fernando Henao-Carrasco, Natalia Palazón-Carrión, Luz M Rodríguez, Isaac Ceballos Lenza, Maribel Casas, Sara Benito, Massimo Chiesa, Susana Bezares, Rosalia Caballero, Carlos Jiménez-Cortegana, Víctor Sánchez-Margalet, Federico Rojo
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. Cancers 13 (21) (2021)
Ivette Mourani Padrón, Jonathan González García, Ruth Tramontani Ramos, Isaac Ceballos Lenza, Fernando Gutiérrez Nicolás
Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (6) (2020)